Find Research Projects

Search results

• 14-GI-93-NLG (NLG 0505) HyperAcute vaccine for locally advanced pancreatic cancer

  Mathew, A., Anthony, L., Kudrimoti, M., Myers, A., St Clair, W., Goel, G. & Hosein, P.

  NewLink Genetics

  1/21/15 → 7/31/17

  Project: Research project

• 14-GI-94-OI (OX4219S) Rollover fosbretabulin study in NET patients with elevated biomarkers

  Anthony, L.

  Pharm Olam International

  4/20/15 → 9/30/17

  Project: Research project

• 14-GU-65-TP (105RC101) Axitinib/TRC105 trial for advanced/metatstatic renal cell carcinoma

  Wang, P.

  2/6/15 → 1/16/20

  Project: Research project

• 14-HEM-05-SA (TED12414) Extension study for patients benefiting from treatment on ARD12130

  Fleischman, R.

  Sanofi Aventis US Inc

  1/1/14 → 10/31/14

  Project: Research project

• 14-HN-25-AZ (D419300003) Combination of MEDI-4736 and tremelimumab in H&N cancer

  Arnold, S.

  AstraZeneca Pharmaceuticals AB

  2/12/15 → 5/1/18

  Project: Research project

• 14-HN-26-AZ (D4193C00001): A Phase II, Multi-Center, Single-Arm, Global Study of MEDI4736 Monotherapy in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

  Arnold, S.

  AstraZeneca Pharmaceuticals AB

  1/27/15 → 6/30/18

  Project: Research project

• 14-LEUK-08-MP: (MDS-15) Pracinostat combined with standard therapy in resistant MDS

  Shakil, S.

  8/14/14 → 7/30/16

  Project: Research project

• 14-LUN-96-CC (ABI-007-NSCL-003) Abraxane plus carboplatin in squamous cell carcinoma of the lung

  Arnold, S.

  Celgene

  6/1/15 → 8/31/15

  Project: Research project

• 14-MEL-08-NS: (CL-CA-P01) Phase III for metastatic melanoma DC-TC vs placebo

  Wang, P.

  11/18/14 → 4/30/16

  Project: Research project

• 14-MYEL-06-AB (Array-520-215): A Multicenter Phase II Study of Single-agent Filanesib(ARRY-520-215) in Patients with Advanced Multiple Myeloma

  Monohan, G.

  ICON Clinical Research

  11/6/14 → 4/13/18

  Project: Research project

• 14-MYEL-07-AB (Array-520-311) Filanesib and carfilzomib treatment of relapsed/refractory multiple myeloma

  Monohan, G.

  ICON Clinical Research

  11/21/14 → 12/31/15

  Project: Research project

• 14-MYEL-09-CC (CC-4047-MM-007) Phase 3 comparing PVd vs Vd in R/R Myeloma

  Monohan, G.

  Celgene

  6/1/15 → 8/31/15

  Project: Research project

• 14-NEURO-05-NL 2013-130 NovoTTF-100A therapy for refractory CNS involved small cell lung cancer

  Villano, J.

  Novocure Ltd

  11/18/14 → 4/9/18

  Project: Research project

• 14th Annual KSCHIRT Symposium 2008

  Sullivan, P.

  National Institute of Neurological Disorders & Stroke

  7/1/08 → 5/31/09

  Project: Research project

• 14th North American Colloquium on Animal Cytogenetics & Gene Mapping

  Lear, T.

  5/1/05 → 4/30/06

  Project: Research project

• 15-28-HN-28-GT (GT-201): A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Effects of Intravenous GC4419 on the Incidence and Duration of Severe Oral Mucositis (OM) in Patients Receiving Post-Operative or Definitive Therapy

  Kudrimoti, M., Arnold, S., St Clair, W. & Thind, R.

  Galera Therapeutics Incorporated

  2/24/16 → 2/23/18

  Project: Research project

• 15-GBM-10-IT (ICT-107-301) A Phase III study of ICT-107 plus maintenance temozolomide (TMZ) in newly diagnosed GBM

  Villano, J., St Clair, W. & Thind, R.

  ImmunoCellular Therapeutics Limited

  12/3/15 → 5/2/18

  Project: Research project

• 15-GI-95-NLG (NLG2104): A Phase 1/2 Study of Indoximod in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Adenocarcinoma of the Pancreas

  Anthony, L., Goel, G., Hosein, P. & Mathew, A.

  NewLink Genetics

  9/21/15 → 9/13/19

  Project: Research project

• 15-GYN-03-GI (CL-PTL-119) Trial of Maintenance FANG

  Ueland, F.

  Gradalis Incorporated

  8/3/15 → 10/6/23

  Project: Research project

• 15-HN-27-AZ (D4193C00002) MEDI4736 Monotherapy and MEDI4736 plus Tremelimumab Vs Standard of Care in SCCHN

  Arnold, S., Anthony, L., Thind, R. & Hosein, P.

  Pharmaceutical Research Associates

  12/14/15 → 10/27/19

  Project: Research project

• 15-ID-200: An Open-label Safety Assessment of Rebiotix RBX2660 (microbiota suspension) for the Treatment of Recurrent Clostridium difficile Infection (PUNCH SOS)

  Greenberg, R.

  Rebiotix Inc

  9/15/15 → 12/5/20

  Project: Research project

• 15-LUN-100-HR: A Phase III, Open-label, Randomized Study of Atezolizumab (MPDL3280A, ANTI-PD-L1 Antibody) in Combination With Carboplatin or Cisplatin + Pemetrexed In Patients Who Are Chemotherapy-Naive and Have Stage IV Non-Squamous

  Arnold, S., Anthony, L., Thind, R., Villano, J. & Hosein, P.

  Genentech Inc

  4/29/16 → 10/20/20

  Project: Research project

• 15-LUN-97-G1T (G1T-28-02) G1T28 in Patients with Extensive-Stage SCLC receiving Etoposide+Carboplatin Chemotherapy

  Arnold, S., Anthony, L., Thind, R., Villano, J. & Hosein, P.

  G1 Therapeutics Incorporated

  1/20/16 → 7/19/18

  Project: Research project

• 15-NEURO-06-NLG (NLG-2102) A Phase 1/2 Study of the Combination of Indoximod + Temozolomide for Adult Patients with Temozolomide-Refractory Primary Malignant Brain Tumors

  Villano, J., St Clair, W. & Thind, R.

  NewLink Genetics

  3/4/16 → 11/14/19

  Project: Research project

• 16-BRE-49-MK A Randomized, Double-Blind, Phase III Study of Pembrolizumab (MK-3475) plus Chemotherapy vs Placebo plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer(KEYNOTE-355)

  Mathew, A.

  7/1/16 → 11/30/16

  Project: Research project

• 16-BRE-50-PU (PUMA-NER-1301) A Study of Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients with Her2+ Metastatic Breast Cancer Who Have Received Two or More Prior Her2-Directed Regimens in the Metastatic Setting

  Mathew, A.

  1/23/17 → 5/16/18

  Project: Research project

• 16-BRE-51-MI (MDV3100) ENDEAR: A Phase 3, Randomized, International Study Comparing the Efficacy and Safety of Enzalutamide in Combination With Paclitaxel Chemotherapy or as Monotherapy Versus Placebo With Paclitaxel in Patients

  Mathew, A.

  12/4/16 → 5/10/17

  Project: Research project

• 16-GBM-12-BE (BXQ-350-AA) Phase 1, Dose-Escalation, Open-label, Safety and Pharmacokinetic, First in Human Study of BXQ-350 Administered as a Single Agent by Intravenous Infusion in Adult Patients with Advanced Solid Tumors and Glioblastoma Multiforme

  Villano, J.

  CTI Clinical Trial and Consulting Services

  3/21/17 → 12/31/21

  Project: Research project

• 16-GI-100-NP (PDR001) An Open Label Phase II Study to Evaluate the Efficacy and Safety of PDR001 in Patients with Advanced or Metastatic Non-Functional Neuroendocrine Tumors of Pancreatic, Gastrointestinal (GI), or Thoracic Origin, Who Have Progressed

  Anthony, L. & Arnold, S.

  Novartis (domestic)

  4/19/17 → 1/23/19

  Project: Research project

• 16-GU-69-AS (9785-MA-1010) A Randomized Study of Enzalutamide in Patients with Localized Prostate Cancer Undergoing Active Surveillance (ENACT)

  Strup, S.

  Astellas Pharma Global Development Incorporated

  6/1/16 → 12/31/16

  Project: Research project

• 16-HEM-07-PP (13-601) A Phase 1/2A Open-Label, Multi-Dose, Multi-Center Escalation and Exploratory Study of Cerdulatinib (PRT062070) in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma

  Saeed, H. & Zia, M.

  1/27/17 → 1/23/19

  Project: Research project

• 16-HEM-08-IN (INCB-50465-202) A Phase 2, Multicenter, International, Open-Label, Safety and Efficacy Study of INCB050465 in Subjects With Relapsed of Refractory Diffuse Large B-Cell Lymphoma

  Saeed, H. & Zia, M.

  4/6/17 → 12/6/18

  Project: Research project

• 16-HEM-09-IN (INCB18424-271) A Single-Cohort, Phase 2 Study of Ruxolitinib in Combination With Corticosteroids for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease

  Hildebrandt, G.

  3/22/17 → 12/3/18

  Project: Research project

• 16-ID-203: A Multicenter, Double-Blind, Parallel-Arm, Placebo-Controlled, Phase 2 Study of the Efficacy, Safety, and Tolerability of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects with Recurrence of Clostridium Difficile Infection

  Greenberg, R., Caudill, T., Flomenhoft, D. & Myint, T.

  Crestovo LLC

  5/16/17 → 4/15/20

  Project: Research project

• 16-LEUK-12-AC (API-01) A Phase I/II Study of Lintuzumab-Ac225 in Older Patients with Untreated Acute Myeloid Leukemia

  Hildebrandt, G.

  1/18/17 → 1/10/19

  Project: Research project

• 16-MULTI-15-SI: An Open-Label Study of Rovalpituzumab Tesirine in Subjects with for Delta-Like Protein-Expressing Advanced Solid Tumors

  Anthony, L., Arnold, S., Villano, J. & Wang, P.

  Stemcentrx Incorporated

  9/27/16 → 7/10/20

  Project: Research project

• 16MULTI-16-HI (HALO-107-101) A Phase 1b Open-Label Study of PEGylated Recombinant Human Hyaluronidase (PEGPH20) Combined with Pembrolizumab in Subjects with Selected Hayluronan-High Solid Tumors

  Arnold, S.

  Medpace Inc

  7/1/16 → 10/31/16

  Project: Research project

• 17-GBM-13-BB (BBI-DSP7888-201G) A Randomized, Multicenter, Phase 2 Study of DSP-7888

  Villano, J.

  Inc Research Inc

  11/7/17 → 2/3/22

  Project: Research project

• 17-GYN-05-XB (VX-EC-2-02) A Phase 2, Single-Arm, Two Period Study of Sodium Cridanimod in Conjunction With Progestin Therapy in Patients With Endometrial Carcinoma

  Baldwin Branch, L.

  Xenetic Biosciences Incorporated

  9/15/17 → 6/10/19

  Project: Research project

• 17-HEM-10-IN (INCB-18424-365) A Phase III, randomized, open-label, multi-center Study of ruxolitinib versus best available therapy in patients with corticosteroid-refractory chronic graft versus host disease after allogenic stem cell transplantation

  Ramlal, R.

  Incyte Corporation

  3/24/17 → 9/25/19

  Project: Research project

• 17-ID-206: A Phase 4 Study to Assess the Safety and Immunogenicity of VAXCHORA (Cholera Vaccine, Live, Oral) in Children 2 to <18 Years of Age (PXVX-VC-200-006)

  Greenberg, R.

  PaxVax Incorporated

  8/17/17 → 8/1/19

  Project: Research project

• 17-ID-207: A Phase 3 Prospective, Randomized, Double-Blind, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of Rebiotix RBX2660 (microbiota suspension) for the Prevention of Recurrent Clostridium difficile Infection

  Greenberg, R.

  Rebiotix Inc

  8/22/17 → 3/21/22

  Project: Research project

• 17-LUN-103-TS(3000-02-001) Niraparib Administered Alone & in Combination with Pembrolizumab in NSCLC

  Arnold, S.

  Tesaro Incorporated

  3/20/18 → 10/30/18

  Project: Research project

• 17-LUN-104-HR Multiple Targeted Therapies for Advanced or Metastatic NSCL Harboring Actionable Mutations in Blood

  Arnold, S.

  Genentech Inc

  2/27/18 → 10/21/20

  Project: Research project

• 18-HEM-12-PC (PCYC-1140-IM) A Randomized, Double-Blind Phase 3 Study of ibrutinib in Combination With Corticosteroids versus Placebo in Combination With Corticosteroids in Subjects with New Onset Chronic Graft Versus Host Disease (cGVHD)

  Ramlal, R.

  AbbVie Incorporated

  8/15/18 → 3/26/20

  Project: Research project

• 18-LUN-105-UT (DIV-SCLC-301) A Two-Part, Open-Label, Randomized, Phase II/III Study of Dinutuximab and Irinotecan versus Irinotecan for Second Line Treatment of Subjects with Relapsed or Refractory SCLC

  Arnold, S.

  United Therapeutics Corporation

  6/28/18 → 3/6/19

  Project: Research project

• 18-LUN-106-BMS (CA209816) Randomized, Open-Label, Phase 3 Trial of Nivolumab plus Ipilimumab or Nivolumab plus Platinum-Doublet Chemotherapy versus Platinum-Doublet Chemotherapy in Early Stage NSCLC

  Villano, J.

  Bristol Myers Squibb Company

  8/16/18 → 8/24/23

  Project: Research project

• 18-NHL-22-JT (17006) A Phase 2 study of JCAR017 as Second-Line Therapy in Adult Patients with Aggressive B-cell NHL

  Iragavarapu, C. & Hildebrandt, G.

  Juno Therapeutics Incorporated

  9/25/18 → 9/21/23

  Project: Research project

• 19-20 Restricted Carryforward Scope Account: Ryan White Title IV Women, Infants, Children, Youth and Affected Family Members

  Thornton, A., El Haddad, H., Fanucchi, L., Forster, D., Holleman, D., Karki Maskey, M., Leedy, N., McTigue, S., Myint, T., Olafsdottir, L., Schaninger, T. & Murphy, B.

  Health Resources and Services Administration

  8/1/12 → 7/31/20

  Project: Research project

• 1968: A Dramatic Moment in American Political History and Culture

  Wilkinson, D.

  12/1/08 → 3/31/09

  Project: Research project